CSRA Renal Services Named Patient Impact Award Finalist
Company Announcement

CSRA Renal Services Named Finalist for athenahealth's Patient Impact Award

Congratulations, CSRA Renal Services. athenahealth Patient Impact Award finalist. 54.2% fewer at-risk blood pressure readings, 62.1% fewer critical readings, 42% of monitored readings within normal limits by December.

CSRA Renal Services has been named one of three finalists, chosen from roughly 3,500 to 4,000 entries nationwide, for athenahealth's 2026 Patient Impact Award, part of the Thrive Customer Excellence Awards. The practice will be recognized on the Thrive mainstage in Nashville on November 4, and we couldn't be prouder to have played a part in their story.

The Challenge: Care Doesn't Stop at the Office Door

For a nephrology practice, the stakes of what happens between visits are high. Patients managing chronic kidney disease often live with hypertension and multiple other chronic conditions that need attention well beyond a scheduled appointment. CSRA's team wanted a way to stay connected to their patients, catch concerning trends earlier, and offer meaningful support in the gap between visits, without bolting on another disconnected system.

The Approach: RPM and CCM, Built on the Platform They Already Trust

CSRA implemented Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) through Nsight Health. A deciding factor in that choice: Nsight Health's status as an athenahealth Marketplace partner. As an athenahealth practice, CSRA wanted a solution that complemented their existing technology and clinical workflows, not a disconnected one.

With RPM in place, patients submit blood pressure readings from home that are monitored on an ongoing basis. Instead of waiting for the next nephrology appointment to discover a consistently elevated reading, CSRA's clinical team can identify concerning trends as they develop. CCM adds another layer of support for patients navigating kidney disease, hypertension, medications, and other chronic care needs.

The Outcome: A Year of Sustained, Measurable Improvement

From January through December 2025, CSRA saw meaningful, sustained improvement. Not a one-month blip, but proof the model works as an ongoing part of care.

54.2%Relative reduction in at-risk blood pressure readings (35.69% to 16.33%)
62.1%Relative reduction in critical blood pressure readings (16.34% to 6.20%)
42.07%Of all monitored readings within normal limits by December

These weren't numbers CSRA took at face value, either. Before putting them in front of athenahealth, the team went back and checked every figure against their own monthly service reports. They held up.

"Our partnership with Nsight Health demonstrates what innovation can accomplish when technology is implemented with a clear patient-centered purpose. We identified a gap in the traditional model of care, selected an athenahealth Marketplace partner that complemented our existing infrastructure, and used RPM and CCM to create a more continuous and proactive approach to kidney care."

Ronald Reynolds, Jr., Practice Manager, CSRA Renal Services

The Patient Perspective

Numbers tell part of the story. The relationships tell the rest.

"I've never met my care team in person, but they feel like family. They remember me, they listen, and I know someone's always looking out for me."

CSRA Renal Services patient, RPM program

What's Next

CSRA will be recognized alongside two other finalists at athenahealth's Thrive conference on November 4. Regardless of the outcome, being selected as a finalist out of athenahealth's full customer base is real validation of the work CSRA's team has put into reimagining care between visits. Congratulations to Ronald Reynolds, Jr. and the entire CSRA Renal Services team.

Company AnnouncementRemote Patient Monitoring (RPM)Chronic Care Management (CCM)Clinical Evidence
A joint patient success story

See what Nsight Health's continuous monitoring can do for your patients.

Book a 30-minute strategy session with one of our people. No obligation.

HIPAASOC 2BBB A+